Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.

Saved in:

Bibliographic Details
Title:	Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.
Authors:	Stoler-Barak L; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Petrovich E; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Aychek T; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Gurevich I; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Tal O; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Hatzav M; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Ilan N; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Feigelson SW; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Shakhar G; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Vlodavsky I; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Alon R; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel; and Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel ronen.alon@weizmann.ac.il.
Source:	FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2015 May; Vol. 29 (5), pp. 2010-21. Date of Electronic Publication: 2015 Jan 29.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info:	Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1530-6860
DOI:	10.1096/fj.14-265447